BioPorto Diagnostics
Ninfa M. Saunders holds extensive experience in healthcare leadership, currently serving on the Board of Directors for Horizon Blue Cross Blue Shield of New Jersey and BioPorto Diagnostics A/S, among other organizations. Notable roles include serving as a member of the Board of Directors for Quorum Health and T2 Biosystems, and Vice Chairman of the Board for healthPrecision since 2020. Previously, Ninfa M. Saunders was President and CEO of Navicent Health and held the position of President at Virtua Health. Educational credentials include a Doctorate in Health Administration from the Medical University of South Carolina, an MBA from Emory University, and a Master’s in Nursing from Rutgers University, complemented by a BSN from Concordia College.
This person is not in any teams
This person is not in any offices
BioPorto Diagnostics
2 followers
BioPorto Diagnostics - Buy antibodies, immunoassays and a market-leading acute kidney injury biomarker, The NGAL Test - use both human urine and plasma.